Literature DB >> 15374574

Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study.

Kiyoto Kasai1, Robert W McCarley, Dean F Salisbury, Toshiaki Onitsuka, Susan Demeo, Deborah Yurgelun-Todd, Ron Kikinis, Ferenc A Jolesz, Martha E Shenton.   

Abstract

A high prevalence of abnormal cavum septi pellucidi (CSP) in schizophrenia may reflect neurodevelopmental abnormalities in midline structures of the brain. The relationship, however, between abnormal CSP and clinical symptoms, and with abnormalities in other limbic structures remains unclear, as does the question of whether a similar abnormality is present in affective psychosis. Seventy-four patients at their first hospitalization, 33 with schizophrenia and 41 with affective (mainly manic) psychosis, and 56 healthy control subjects underwent high-spatial-resolution magnetic resonance imaging (MRI). CSP on six slices or more on 0.9375-mm resampled coronal images was categorized as abnormal. The prevalence of abnormal CSP in both schizophrenic patients (26.1%) and affective psychosis patients (18.2%) was significantly higher than was observed in control subjects (8.2%). In schizophrenic patients only, larger CSP was significantly associated with more severe thinking disturbance and smaller left parahippocampal gyrus gray matter volumes. While the relationships between CSP ratings and clinical symptoms did not significantly differ between the two psychosis groups as assessed by the comparison of regression slopes, the association with limbic volumes appeared to be specific to schizophrenic patients. These results suggest that psychosis associated with schizophrenia and affective disorder share, at least to some extent, neurodevelopmental abnormalities involving midline structures and associated psychopathological consequences. However, the association between abnormal CSP and limbic systems may be more specific to schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15374574      PMCID: PMC2811876          DOI: 10.1016/j.schres.2003.12.010

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  37 in total

1.  Prefrontal gray matter volume reduction in first episode schizophrenia.

Authors:  Y Hirayasu; S Tanaka; M E Shenton; D F Salisbury; M A DeSantis; J J Levitt; C Wible; D Yurgelun-Todd; R Kikinis; F A Jolesz; R W McCarley
Journal:  Cereb Cortex       Date:  2001-04       Impact factor: 5.357

2.  Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia.

Authors:  L E DeLisi; M Sakuma; W Tew; M Kushner; A L Hoff; R Grimson
Journal:  Psychiatry Res       Date:  1997-07-04       Impact factor: 3.222

3.  Nonlinear anisotropic filtering of MRI data.

Authors:  G Gerig; O Kubler; R Kikinis; F A Jolesz
Journal:  IEEE Trans Med Imaging       Date:  1992       Impact factor: 10.048

4.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

Review 5.  The septum pellucidum: normal and abnormal.

Authors:  M Sarwar
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

6.  Cava septi pellucidi et vergae: their normal and pathogical states.

Authors:  C M Shaw; E C Alvord
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

7.  Cavum septi pellucidi and cavum vergae in normal and developmentally delayed populations.

Authors:  J B Bodensteiner; G B Schaefer; J M Craft
Journal:  J Child Neurol       Date:  1998-03       Impact factor: 1.987

8.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.

Authors:  D H Mathalon; E V Sullivan; K O Lim; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  2001-02

9.  Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study.

Authors:  C G Wible; M E Shenton; H Hokama; R Kikinis; F A Jolesz; D Metcalf; R W McCarley
Journal:  Arch Gen Psychiatry       Date:  1995-04

10.  Fusiform gyrus volume reduction in first-episode schizophrenia: a magnetic resonance imaging study.

Authors:  Chang Uk Lee; Martha E Shenton; Dean F Salisbury; Kiyoto Kasai; Toshiaki Onitsuka; Chandlee C Dickey; Deborah Yurgelun-Todd; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley
Journal:  Arch Gen Psychiatry       Date:  2002-09
View more
  14 in total

1.  Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure.

Authors:  Roger K Pitman; Mark W Gilbertson; Tamara V Gurvits; Flavia S May; Natasha B Lasko; Linda J Metzger; Martha E Shenton; Rachel Yehuda; Scott P Orr
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

2.  Midline Brain Abnormalities Across Psychotic and Mood Disorders.

Authors:  Ramón Landin-Romero; Benedikt L Amann; Salvador Sarró; Amalia Guerrero-Pedraza; Victor Vicens; Elena Rodriguez-Cano; Eduard Vieta; Raymond Salvador; Edith Pomarol-Clotet; Joaquim Radua
Journal:  Schizophr Bull       Date:  2015-07-17       Impact factor: 9.306

3.  MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder.

Authors:  Chandlee C Dickey; Robert W McCarley; Mina L Xu; Larry J Seidman; Martina M Voglmaier; Margaret A Niznikiewicz; Erin Connor; Martha E Shenton
Journal:  Schizophr Res       Date:  2006-10-05       Impact factor: 4.939

4.  Volumetric analysis of septal region in schizophrenia and affective disorder.

Authors:  Ralf Brisch; Hans-Gert Bernstein; Dieter Krell; Renate Stauch; Kurt Trübner; Henrik Dobrowolny; Siegfried Kropf; Hendrik Bielau; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-16       Impact factor: 5.270

5.  Radiological findings in individuals at high risk of psychosis.

Authors:  S J Borgwardt; E-W Radue; K Götz; J Aston; M Drewe; U Gschwandtner; S Haller; M Pflüger; R-D Stieglitz; P K McGuire; A Riecher-Rössler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

6.  Cavum septum pellucidum in schizophrenia: clinical and neuropsychological correlates.

Authors:  Laura A Flashman; Robert M Roth; Heather S Pixley; Howard B Cleavinger; Thomas W McAllister; Robert Vidaver; Andrew J Saykin
Journal:  Psychiatry Res       Date:  2007-02-07       Impact factor: 3.222

7.  Association of complement component 4 with neuroimmune abnormalities in the subventricular zone in schizophrenia and autism spectrum disorders.

Authors:  Ta-Chung M Mou; Malcolm V Lane; Derek D C Ireland; Daniela Verthelyi; Leonardo H Tonelli; Sarah M Clark
Journal:  Neurobiol Dis       Date:  2022-08-19       Impact factor: 7.046

8.  Cerebral connectivity and psychotic personality traits. A diffusion tensor imaging study.

Authors:  Umberto Volpe; Andrea Federspiel; Armida Mucci; Thomas Dierks; Anders Frank; Lars-Olof Wahlund; Silvana Galderisi; Mario Maj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

9.  MRI study of the cavum septum pellucidum in obsessive-compulsive disorder.

Authors:  Myong-Wuk Chon; Jung-Seok Choi; Do-Hyung Kang; Myung Hun Jung; Jun Soo Kwon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-25       Impact factor: 5.270

10.  Enlarged cavum septum pellucidum as a neurodevelopmental marker in adolescent-onset opiate dependence.

Authors:  Jaeuk Hwang; Jieun E Kim; Marc J Kaufman; Perry F Renshaw; Sujung Yoon; Deborah A Yurgelun-Todd; Yera Choi; Chansoo Jun; In Kyoon Lyoo
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.